Compare M&T Bank Corporation (MTB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: M&T Bank Corporation pays a 2.41% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| MTB | XBI | |
|---|---|---|
Market Cap | $36.15B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $254.04 | $164.28 |
52-Week Low | $178.63 | $85.16 |
Dividend Yield | 2.41% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
